These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21360915)

  • 1. [Smoking enhances the decrease of adiponectin level in patients with coronary artery disease, carriers of MTHFR 677T and PON1 55M alleles].
    Strauss E; Radziemski A; Głuszek J; Pawlak A
    Przegl Lek; 2010; 67(10):859-65. PubMed ID: 21360915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and hypertension related changes in genotypes of MTHFR 677C>T, 1298A>C and PON1 -108C>T SNPs in men with coronary artery disease (CAD).
    Strauss E; Głuszek J; Pawlak AL
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():65-75. PubMed ID: 16077191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The different genotypes of MTHFR 1298A>C and PON1 -108C>T polymorphisms confer the increased risk of the abdominal aortic aneurysm in the smoking and nonsmoking persons].
    Strauss E; Waliszewski K; Pawlak AL
    Przegl Lek; 2005; 62(10):1023-30. PubMed ID: 16521945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
    Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
    Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between homocysteine and genes of folate-related enzymes in migraine patients.
    Oterino A; Toriello M; Valle N; Castillo J; Alonso-Arranz A; Bravo Y; Ruiz-Alegria C; Quintela E; Pascual J
    Headache; 2010 Jan; 50(1):99-168. PubMed ID: 19619240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
    Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage.
    Botto N; Andreassi MG; Manfredi S; Masetti S; Cocci F; Colombo MG; Storti S; Rizza A; Biagini A
    Eur J Hum Genet; 2003 Sep; 11(9):671-8. PubMed ID: 12939653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
    Balcerzyk A; Zak I; Krauze J
    Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
    Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.
    Yilmaz H; Isbir S; Agachan B; Ergen A; Farsak B; Isbir T
    Cell Biochem Funct; 2006; 24(1):87-90. PubMed ID: 15648053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-gene interaction affects coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrao M; Ornelas I; Freitas S; Freitas C; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2009 Apr; 28(4):397-415. PubMed ID: 19634497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
    Qin Q; Li YL; Zhao FM; Wang H; Li Y; Cui RZ; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):803-7. PubMed ID: 17217688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.